Ricardo Alonso-zaldivar, The Associated Press

Ricardo Alonso-zaldivar

The Associated Press

San Antonio, TX, United States

Contact Ricardo

Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.

Start free trial

Recent:
  • The Boston Globe
  • ABC News
  • Business Insider
  • FOX 8 New Orleans
  • 13WHAM
  • KABB FOX 29
  • FOX 5 DC
  • WDRB News
  • WPTV
  • seattlepi
  • The Associated Press
  • News 4 San Antonio
  • FOX 10 Phoenix
  • CBS46
  • WSYX ABC 6
  • The Denver Post
  • KCTV5 - Kansas City
  • Cashay
  • FOX Baltimore
Past:
  • FOX Carolina News
  • WGRZ
  • ABC 33/40 News
  • FOX 11 Los Angeles
  • KATU News
  • WTOL 11
  • WIS News 10
  • FOX 5 Las Vegas
  • SavannahNow
  • NBC12 WWBT Richmond
  • and more…

Recent articles by Ricardo:

Trump makes late-term bid to lower prescription drug costs

In a time of political uncertainty, it’s hard to say whether the rules will withstand expected legal challenges from the pharmaceutical industry or whether President-elect Joe Biden's administration will accept, amend or try to roll them back entirely. → Read More

Trump makes late-term bid to lower prescription drug costs

President Donald Trump's administration is trying to close out major unfinished business on lowering prescription drug costs → Read More

Trump makes late-term bid to lower prescription drug costs

President Donald Trump's administration is trying to close out major unfinished business on lowering prescription drug costs → Read More

Trump makes late-term bid to lower prescription drug costs

Trying to close out major unfinished business, the Trump administration issued regulations Friday that could lower the prices Americans pay for many prescription drugs. → Read More

Trump makes late-term bid to lower prescription drug costs

President Donald Trump's administration is trying to close out major unfinished business on lowering prescription drug costs → Read More

Trump announced new rules intended to lower prescription drug costs in a late-term effort to fulfill one of his campaign promises

Trying to close out major unfinished business, Trump issued regulations Friday that could lower the prices Americans pay for many prescription drugs. → Read More

Coalition seizes on pandemic to boost 'Obamacare' sign-ups

A coalition of states, health care groups and activists is striving to drum up “Obamacare” sign-ups among millions of uninsured Americans as the coronavirus spreads uncontrolled in many communities → Read More

Coalition seizes on pandemic to boost ‘Obamacare’ sign-ups

As COVID-19 spreads uncontrolled in many places, a coalition of states, health care groups and activists is striving to drum up “Obamacare” sign-ups among a growing number of Americans uninsured in perilous times. → Read More

Biden team ponders vaccine plans as Trump stalls handoff

The president-elect’s outreach to vaccine manufacturers comes as the coronavirus pandemic in the United States has entered perhaps its most dangerous phase. → Read More

Biden seeks window on vaccine plans as Trump stalls handoff

President-elect Joe Biden's scientific advisers plan to meet with vaccine makers in coming days even as a stalled presidential transition keeps them out of the loop on government plans to inoculate all Americans against COVID-19. → Read More

Biden seeks window on vaccine plans as Trump stalls handoff

President-elect Joe Biden's scientific advisers plan to meet with vaccine makers in coming days even as a stalled presidential transition keeps them out of the loop on government plans to inoculate all Americans against COVID-19. → Read More

Biden advisers to meet vaccine firms as presidential transition stalled

Joe Biden’s scientific advisers will meet with vaccine makers in coming days as the presidential transition remains stalled because of President Donald Trump’s refusal to acknowledge that he lost the election. → Read More

Biden advisers to meet vaccine firms as Trump stalls handoff

Joe Biden’s scientific advisers will meet with vaccine makers in coming days as the presidential transition remains stalled because of President Donald Trump’s refusal to acknowledge that he lost the election → Read More

Biden advisers to meet vaccine firms as Trump stalls handoff

WASHINGTON (AP) — Joe Biden's scientific advisers will meet with vaccine makers in coming days as the presidential transition remains stalled because of President Donald Trump's refusal to acknowledge that → Read More

Biden advisers to meet vaccine firms as Trump stalls handoff

Joe Biden’s scientific advisers will meet with vaccine makers in coming days as the presidential transition remains stalled because of President Donald Trump’s refusal to acknowledge that he lost the election → Read More

Biden advisers to meet with vaccine firms as Trump stalls handoff

President-elect Biden's outreach to the vaccine manufacturers comes as the coronavirus pandemic in the United States has entered perhaps its most dangerous phase. → Read More

Biden advisers to meet vaccine firms as Trump stalls handoff

Joe Biden's scientific advisers will meet with vaccine makers in coming days as the presidential transition remains stalled because of President Donald Trump's refusal to acknowledge that he lost the election. → Read More

Biden advisers to meet vaccine firms as Trump stalls handoff

WASHINGTON (AP) — Joe Biden's scientific advisers will meet with vaccine makers in... → Read More

Biden advisers to meet vaccine firms as Trump stalls handoff

WASHINGTON (AP) — Joe Biden's scientific advisers will meet with vaccine makers in coming days as the presidential transition remains stalled because of President Donald Trump's refusal to... → Read More

Biden advisers to meet vaccine firms as Trump stalls handoff

WASHINGTON (AP) — Joe Biden's scientific advisers will meet with vaccine makers in coming days as the presidential transition remains stalled because of President Donald Trump's refusal to acknowledge that he lost the election. That delayed handoff to the next administration is especially problematic during a public health crisis, the government's top infectious disease expert said. "Of course… → Read More